跳至主要内容
临床试验/NCT02969642
NCT02969642Unknown2 期

A Single-center, Sham-controlled, Single Attack Study of Laser Therapy to the Sphenopalatine Ganglion (SPG) in the Acute Treatment of Migraine

The San Francisco Clinical Research Center1 个研究点 分布在 1 个国家目标入组 60 人开始时间: 2016年3月1日最近更新:
适应症
干预措施

试验速览

阶段
2 期
发起方
入组人数
60
试验地点
1
主要终点
Differences between treatment groups in pain free rates at 2 hours post treatment.

研究概览

简要总结

This study evaluates the treatment of migraine pain using low energy laser light to quench migraine signals issuing from the sphenopalatine ganglion (SPG).

详细描述

This is a double blinded, two arm study, comprising a sham laser and a treatment laser. The sham laser emits approximately 1/1000 the energy of the treatment laser.

It is presumed that pain relief from the treatment laser is achieved by exhausting the release of neurotransmitters from the SPG following laser stimulation. Subjects will be treated and subsequently queried at time intervals for their self-assessment of pain score (VAS). The time intervals include queries at 5 minutes through 2 hours post treatment. Subjects will be further contacted 24 hours and one month post treatment. Adverse events will be monitored and recorded.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Triple (Participant, Care Provider, Investigator)

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者
否

入选标准

  • •male or female
  • •aged 18 or older;
  • •subject diagnosed with migraine according to The International Classification of Headache Disorders- Version 3;
  • •1-20 headache days per month;
  • •history of at least moderate pain if migraine left untreated.

排除标准

  • •headache on greater than 25 days/month on average for preceding 3 months;
  • •headache on greater than 25 days in present month;
  • •headache attributed to: head or neck trauma, cluster headache, specific migraine variants such as basilar artery, ophthalmoplegic, hemiplegic, etc;
  • •women of child bearing age not using acceptable method of contraception;
  • •pregnant or nursing women;
  • •history of malignancy of any organ
  • •uncontrolled: hypertension, severe psychiatric disorders, or known use of narcotics, analgesic or alcohol abuse;
  • •light sensitivity;
  • •retinal disease;
  • •intranasal pathology.

研究组 & 干预措施

Sham

Sham Comparator

Sham low energy laser using approximately 1/1000 th energy of treatment laser.

干预措施: Argus Migraine Treatment device (Device)

Treatment

Active Comparator

Treatment laser.

干预措施: Argus Migraine Treatment device (Device)

结局指标

主要结局

Differences between treatment groups in pain free rates at 2 hours post treatment.

时间窗: 2 hours post treatment

次要结局

未报告次要终点

研究者

发起方
The San Francisco Clinical Research Center
申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验